Abraxane Chemotherapy Medicine

Belonging to a group of chemotherapy medicines known as taxanes, Abraxane® (protein-bound paclitaxel) is a prescription drug used to treat breast cancer. Specifically, it is licensed to treat breast cancer in the following situations:
 
  • Metastatic breast cancer (cancer that has spread to other parts of the body) that has failed to respond to other chemotherapy medications
  •  
  • Breast cancer that has returned within six months of adjuvant chemotherapy (chemotherapy after breast cancer surgery).
  •  
This medication is given through an IV (intravenously), typically at your healthcare provider's office, a hospital, or at an "infusion center." Hair loss, nerve pain, and weakness are some of the most common side effects.
 
(For more information on this chemotherapy medicine, click Abraxane. This article discusses other potential side effects, general dosing guidelines, possible overdose symptoms, and more.)
 

Abraxane Chemotherapy Medicine

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.